- Home
- MDGL vs FRHC Comparison
MDGL vs FRHC Comparison
Compare MDGL & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- FRHC
- Stock Information
- Founded
- MDGL 2011
- FRHC 1981
- Country
- MDGL United States
- FRHC Kazakhstan
- Employees
- MDGL N/A
- FRHC N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- FRHC Investment Bankers/Brokers/Service
- Sector
- MDGL Health Care
- FRHC Finance
- Exchange
- MDGL Nasdaq
- FRHC Nasdaq
- Market Cap
- MDGL 7.4B
- FRHC 7.2B
- IPO Year
- MDGL N/A
- FRHC N/A
- Fundamental
- Price
- MDGL $308.44
- FRHC $127.17
- Analyst Decision
- MDGL Buy
- FRHC
- Analyst Count
- MDGL 14
- FRHC 0
- Target Price
- MDGL $347.33
- FRHC N/A
- AVG Volume (30 Days)
- MDGL 355.8K
- FRHC 79.1K
- Earning Date
- MDGL 10-31-2024
- FRHC 02-07-2025
- Dividend Yield
- MDGL N/A
- FRHC N/A
- EPS Growth
- MDGL N/A
- FRHC 11.75
- EPS
- MDGL N/A
- FRHC 5.68
- Revenue
- MDGL $76,813,000.00
- FRHC $1,306,629,000.00
- Revenue This Year
- MDGL N/A
- FRHC N/A
- Revenue Next Year
- MDGL $194.49
- FRHC N/A
- P/E Ratio
- MDGL N/A
- FRHC $22.38
- Revenue Growth
- MDGL N/A
- FRHC 68.86
- 52 Week Low
- MDGL $168.25
- FRHC $64.00
- 52 Week High
- MDGL $368.29
- FRHC $134.00
- Technical
- Relative Strength Index (RSI)
- MDGL 51.11
- FRHC 58.69
- Support Level
- MDGL $289.80
- FRHC $125.51
- Resistance Level
- MDGL $315.09
- FRHC $134.00
- Average True Range (ATR)
- MDGL 12.44
- FRHC 3.82
- MACD
- MDGL -4.11
- FRHC -0.56
- Stochastic Oscillator
- MDGL 48.58
- FRHC 56.91
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.